当前位置:首页 - 行情中心 - 人福医药(600079) - 财务分析

人福医药

(600079)

  

流通市值:325.30亿  总市值:344.07亿
流通股本:15.43亿   总股本:16.32亿

人福医药(600079)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润14.97亿元,每股收益0.71元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益2140654.47万元,未分配利润1022063.98万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产3755513.50万元,负债1614859.03万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入12,063,918,105.776,137,399,886.0525,435,484,349.4319,143,374,654.64
营业总成本10,297,053,275.115,336,905,257.7922,665,868,260.2216,644,223,107.45
其他经营收益
营业利润1,834,513,499.07857,303,978.422,522,028,5722,655,713,364.77
利润总额1,789,225,532.9827,442,675.242,422,830,341.452,588,983,206.95
净利润1,497,174,002.51698,615,043.071,778,342,930.442,107,380,778.33
每股收益
其他综合收益87,566,822.09-26,945,270.08132,562,352.95121,805,252.07
综合收益总额1,584,740,824.6671,669,772.991,910,905,283.392,229,186,030.4
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计20,737,585,191.420,412,196,364.8319,858,374,856.8820,487,118,563.49
非流动资产:
非流动资产合计16,817,549,830.0116,754,349,681.8216,649,949,124.8716,858,815,919.39
资产总计37,555,135,021.4137,166,546,046.6536,508,323,981.7537,345,934,482.88
流动负债:
流动负债合计13,458,395,710.8813,663,997,789.8113,339,976,221.9413,726,920,913.18
非流动负债:
非流动负债合计2,690,194,630.092,166,083,875.672,475,288,773.312,599,001,250.27
负债合计16,148,590,340.9715,830,081,665.4815,815,264,995.2516,325,922,163.45
所有者权益(或股东权益):
归属于母公司股东权益合计18,335,044,814.1318,134,575,571.2117,623,818,879.0817,868,500,039.82
股东权益合计21,406,544,680.4421,336,464,381.1720,693,058,986.521,020,012,319.43
负债和股东权益合计37,555,135,021.4137,166,546,046.6536,508,323,981.7537,345,934,482.88
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计11,632,352,871.45,447,617,031.7324,697,293,034.1718,308,686,331.63
经营活动现金流出小计10,773,961,034.175,784,396,672.3622,533,027,974.6816,816,007,878.55
经营活动产生的现金流量净额858,391,837.23-336,779,640.632,164,265,059.491,492,678,453.08
投资活动产生的现金流量:
投资活动现金流入小计117,970,742.179,230,501.69482,937,224.92269,348,256.87
投资活动现金流出小计425,795,199.61249,050,876.061,224,962,331.99957,208,979.32
投资活动产生的现金流量净额-307,824,457.44-239,820,374.37-742,025,107.07-687,860,722.45
筹资活动产生的现金流量:
筹资活动现金流入小计5,414,015,255.552,335,229,393.439,860,935,168.76,897,401,726.37
筹资活动现金流出小计5,508,718,869.412,154,055,389.2911,358,932,530.737,861,473,395.93
筹资活动产生的现金流量净额-94,703,613.86181,174,004.14-1,497,997,362.03-964,071,669.56
汇率变动对现金及现金等价物的影响14,449,373.586,805,021.75-23,866,875.3-42,337,124.54
现金及现金等价物净增加额470,313,139.51-388,620,989.11-99,624,284.91-201,591,063.47
期末现金及现金等价物余额3,361,133,397.772,502,199,269.152,890,820,258.262,788,853,479.7
补充资料:
现金及现金等价物的净增加额470,313,139.51--99,624,284.91-
最新报告期:2025-09-25
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
首创证券王斌1.191.451.742025-09-25
太平洋张懿,谭紫媚1.391.501.632025-09-03
申万宏源张静含,陈田甜1.331.471.732025-08-31
华源证券刘闯,李强1.431.571.682025-08-30
开源证券刘艺,余汝意1.391.601.862025-08-28
TOP↑